| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.075 | 0.08 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.09 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.3 | 0.09 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |